Hey BOOB, why do you REFERENCE PAUL....HE HAS PAID $0 for all hos shares, how can you possibly consider him an INVESTOR? He also has been selling every chance he gets....He sees the TRAIN at the end of the Tunnel ready to run him over....Getting out while there is some value....
Sentiment: Strong Sell
That is Great news if you are 100% sure....So if it is true, then #$%$ is holding Paul back from Marketing his company more effectively to a 3rd party...What you are saying is the reason that the group of friends and fund guys purchased nearly 200,000 shares back in 2006-2007....And the videos of the man that had good results in phase 2...If what you are saying is true, then shareholders SHOULD demand that Paul step down and replace with a more competent executive that can get this company sold..
I know what has been posted here, but I can't find any NON PAID comments from actual NX-1207 participants....If I was NYMX, why wouldn't I have a link on my website that interviews t least a few that were in trials,,,
Please show proof of urologist and patient testimonials.....You have access to this but company doesn't share...what lies....There has NEVER been a Single press release of a patient testimonial
You have really no concerns that Paul has sold shares 3 times. You have no concerns that Chief Medical Officer albeit his e wife left company with not even an announcement. You have no concerns that the first 500 people in trials were supposed to be reported on 4Q 2013. You have no problem that not 1 announcement from company since May 8th about when to expect results or what is the delay?
One I am not angry, But I can't stand liars...Go to just about ANY Bio website and you can view company presentations...Paul has presented teh same stuff for 5 years ..why can't shareholders see the presentations
HOW DO YOU KNOW any of the data is good, No one has ever seen a copy of any presentation on ACTUAL data.....REALLY....I can look at online presentations of almost any Biotech and see data points and details ..NOT NYMOX.....YOU must be DELUSIONAL....What a piece of garbage
How can Paul sell shares while knowing any inside information...Are we to believe he has NO CLUE on first 500, or was there some errors in data collection that caused a delay while they did clean up.
I am sorry NO RELEASE is an ADMISSION of PROBLEMS
We only know what we are told by company, however we still have NEVER seen LG show up as an investor nor have they ever filed a 13G so they must be selling, however we also can't really find much about their existence financially, To imply that they are doing things correctly is a leap of faith....If I see BOU or David say its about to take off 1 more time, that BS makes me stay to protect any potential investors from also being scammed
Success rates for experimental drugs falls: study
(Reuters) - The success rate in bringing new medicines to market in recent years is only about half of what it had been previously, but biotech drugs are twice as likely to gain U.S. approval than more traditional chemical drugs, according to a new study released on Monday.
And while oncology has been one of the hottest and most active therapeutic areas for drug development, drugmakers may want to take note of a finding that new cancer drugs have proven far more difficult to gain approval than medicines for infectious and autoimmune diseases.
Drugmakers have been complaining about the difficulty of bringing new products to market in a regulatory climate that has become increasingly unpredictable and more likely to err on the side of safety in deciding risk/benefit ratios of experimental medicines.
Data from this new study appears to bear that out.
"It ain't getting any easier to develop new therapies." said Alan Eisenberg, head of emerging companies and business development for the biotech trade group Biotechnology Industry Organization (BIO), putting the findings succinctly.
"Knowing more about the magnitude of risk can lead to smarter drug development as well as smarter investing," he said.
The study, covering 2004 through 2010, found the overall success rate for drugs moving from early stage Phase I clinical trials to FDA approval is about one in 10 and a mere 4.7% on average
Again its not the issue of if it works....the issue is will men use it.....it took 4 years to find 1000 of the millions of bph sufferers..to whom are they going to sell it? Certainly won't be large numbers....also company credibility is so low, it is possible that it won't be approved....paul a has a poor track record in front of fda.....they do not like condescending and arrogant people...humility is non existent here in my opinion...
Sentiment: Strong Sell
How long does it take to add up 1000 scores and then divide by the appropriate divisor. You really think thi stakes 3,4,5,6 months.....SERIOUSLY
Sentiment: Strong Sell
They reported that it was COMPLETE on May 8th!!!!! That is not June 30th....You LOSE
I guess in Canada, Expeditious means after CEO sells enough stock to retire